Treatment of Depression in Patients with Epilepsy
- 7 April 2011
- journal article
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 13 (4) , 371-379
Abstract
In this article, we review the current best evidence for the treatment of depression in patients with epilepsy. Depression is a common epilepsy comorbidity, but it is often unrecognized. The most important step in appropriately managing mood disorders in this population is making the diagnosis. Clinical vigilance and routine use of a validated screening tool can improve detection and quality of care. As is increasingly the case for the general population, persons with epilepsy are often interested in exploring alternative therapies for chronic conditions, including depression. Unfortunately, the benefit of complementary and alternative therapies for depression currently is largely unproven for persons with a seizure history, although an early study of exercise for mild depression has shown some benefit. Concerns about drug interactions, side effects, and expense may be barriers to the prescription of antidepressant medications for people requiring chronic antiepileptic drug (AED) therapy. For this reason, use of an AED with mood-stabilizing properties has appeal and may be appropriate for selected individuals with mild depressive symptoms. Undue fear of lowering seizure threshold should not preclude the prescription of an antidepressant medication, as the perceived risks are often overestimated and rarely outweigh the risk of leaving depression untreated. At present, the best evidence for efficacy and safety support the use of citalopram, sertraline, or mirtazapine as initial pharmacotherapy, whereas bupropion should be avoided. Start low, go slow, and use the lowest effective dose. Cognitive behavioral therapy is a valuable adjunct to antidepressant therapy in this population. For people with refractory partial epilepsy and refractory depression, vagus nerve stimulation has some appeal, in that it may be beneficial for both conditions, but the efficacy of vagus nerve stimulation in improving mood in patients with epilepsy remains unclear.Keywords
This publication has 40 references indexed in Scilit:
- Psychiatric comorbidity in patients with epilepsy: a population-based studyEuropean Journal of Clinical Pharmacology, 2010
- Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical ObservationsThe AAPS Journal, 2009
- Depression in adults, including those with a chronic physical health problem: summary of NICE guidanceBMJ, 2009
- St John's wort for major depressionCochrane Database of Systematic Reviews, 2008
- Consensus statement: The evaluation and treatment of people with epilepsy and affective disordersEpilepsy & Behavior, 2008
- Rapid detection of major depression in epilepsy: a multicentre studyThe Lancet Neurology, 2006
- The Epidemiology of the Comorbidity of Epilepsy in the General PopulationEpilepsia, 2004
- Complementary/alternative medicine for epilepsy in ArizonaNeurology, 2003
- A Prospective Evaluation of the Effects of a 12-Week Outpatient Exercise Program on Clinical and Behavioral Outcomes in Patients with EpilepsyEpilepsy & Behavior, 2001
- Antiepileptic Therapy, Folate Deficiency, and Psychiatric Morbidity: A General Practice SurveyEpilepsia, 1985